William P. Barry, Partner with Richards Kibbe & Orbe LLP to Speak at The Knowledge Group’s FCPA/Anti-Corruption Compliance in Pharma/Life Sciences Industry
New York, NY, July 08, 2016 --(PR.com)-- The Knowledge Group/The Knowledge Congress Live Webcast Series, the leading producer of regulatory focused webcasts, has announced today that William P. Barry, Partner with Richards Kibbe & Orbe LLP will speak at The Knowledge Group’s webcast entitled: “FCPA/Anti-Corruption Compliance in Pharma/Life Sciences Industry.” This event is scheduled for October 6, 2016 from 12:00pm – 2:00pm (ET).
For further details, please visit: https://theknowledgegroup.org/event/?ID=fcpaanti-corruption-compliance-in-pharmalife-sciences-industry-live-webcast
About William Barry
William Barry is a partner and member of the Executive Committee at Richards Kibbe & Orbe LLP. He advises clients on a broad range of issues involving securities enforcement, white collar and securities fraud litigation, as well as compliance with The Foreign Corrupt Practices Act, money laundering and insider trading requirements.
Mr. Barry guides clients through the complex issues involved in cross-border transactional due diligence and risk mitigation as well as responding to inquiries from the U.S. DOJ, SEC and other domestic and international regulators regarding issues of accounting fraud, foreign bribery and other financial crimes. He also represents clients responding to competing demands in parallel proceedings, such as internal reviews, government investigations and private civil actions.
Mr. Barry has been recognized in the area of White Collar Criminal Defense by The Legal 500 United States and has been designated as a Certified Anti-Money Laundering Specialist by ACAMS.
About Richards Kibbe & Orbe LLP
Richards Kibbe & Orbe LLP has long been a go-to firm in the fields of cross-border enforcement, government investigations and criminal defense. We have a proven record of navigating difficult regulatory and criminal issues, from high profile investigations, parallel criminal and regulatory proceedings to the latest hot-button international enforcement situations.
For 25 years, RK&O has helped clients facing potential scrutiny in multiple jurisdictions and confronting severe civil, criminal and reputational penalties. Our highly skilled team draws on the key attributes of the firm: our renowned white-collar practice, our proficiency in regulatory counseling, our ability to seamlessly manage parallel proceedings and our vast cross-border experience.
The RK&O team understands the enforcement perspective and can foresee future challenges lurking around the corner. We deeply understand the importance of international cooperation and the complications of regulatory exposure in multiple jurisdictions.
Abstract
The U.S. and international enforcement authorities have demonstrated continued focus on the life sciences industry for FCPA and anti-corruption violations as shown by prominent international investigations and intensified government compliance outlooks. This emphasis is critical for mid-market businesses with underdeveloped compliance programs. Clinical research organizations, hospitals, and providers have also high enforcement risks due to healthcare globalization.
Life Sciences companies should know how to respond to this daunting climate and, eventually, battle anti-corruption risk factors which are confronting the industry. This includes more than just direct relationships with government, it includes third party, supply chain and distribution relationships, all of which expose industry participants to FCPA risk.
In this two-hour Live Webcast, a panel of distinguished professionals and thought leaders organized by The Knowledge Group will help Pharma/Life Sciences Industry understand the fundamental and complex aspects of this significant topic. They will provide an in-depth discussion of the various FCPA/Anti-Corruption compliance issues every Pharma/Life Sciences company should know. Speakers will also offer the audience with best practices in developing and implementing an effective compliance and risk management program.
Key topics include:
- FCPA/Anti-Corruption in Pharma/Life Sciences Industry: Current Trends
- Notable Cases for Guidance
- Common Anti-Corruption Risks
- Best Compliance Practices
- Risk Factor Management
About The Knowledge Group/The Knowledge Congress Live Webcast Series
The Knowledge Group was established with the mission to produce unbiased, objective, and educational live webinars that examine industry trends and regulatory changes from a variety of different perspectives. The goal is to deliver a unique multilevel analysis of an important issue affecting business in a highly focused format. To contact or register for an event, please visit: http://theknowledgegroup.org/.
For further details, please visit: https://theknowledgegroup.org/event/?ID=fcpaanti-corruption-compliance-in-pharmalife-sciences-industry-live-webcast
About William Barry
William Barry is a partner and member of the Executive Committee at Richards Kibbe & Orbe LLP. He advises clients on a broad range of issues involving securities enforcement, white collar and securities fraud litigation, as well as compliance with The Foreign Corrupt Practices Act, money laundering and insider trading requirements.
Mr. Barry guides clients through the complex issues involved in cross-border transactional due diligence and risk mitigation as well as responding to inquiries from the U.S. DOJ, SEC and other domestic and international regulators regarding issues of accounting fraud, foreign bribery and other financial crimes. He also represents clients responding to competing demands in parallel proceedings, such as internal reviews, government investigations and private civil actions.
Mr. Barry has been recognized in the area of White Collar Criminal Defense by The Legal 500 United States and has been designated as a Certified Anti-Money Laundering Specialist by ACAMS.
About Richards Kibbe & Orbe LLP
Richards Kibbe & Orbe LLP has long been a go-to firm in the fields of cross-border enforcement, government investigations and criminal defense. We have a proven record of navigating difficult regulatory and criminal issues, from high profile investigations, parallel criminal and regulatory proceedings to the latest hot-button international enforcement situations.
For 25 years, RK&O has helped clients facing potential scrutiny in multiple jurisdictions and confronting severe civil, criminal and reputational penalties. Our highly skilled team draws on the key attributes of the firm: our renowned white-collar practice, our proficiency in regulatory counseling, our ability to seamlessly manage parallel proceedings and our vast cross-border experience.
The RK&O team understands the enforcement perspective and can foresee future challenges lurking around the corner. We deeply understand the importance of international cooperation and the complications of regulatory exposure in multiple jurisdictions.
Abstract
The U.S. and international enforcement authorities have demonstrated continued focus on the life sciences industry for FCPA and anti-corruption violations as shown by prominent international investigations and intensified government compliance outlooks. This emphasis is critical for mid-market businesses with underdeveloped compliance programs. Clinical research organizations, hospitals, and providers have also high enforcement risks due to healthcare globalization.
Life Sciences companies should know how to respond to this daunting climate and, eventually, battle anti-corruption risk factors which are confronting the industry. This includes more than just direct relationships with government, it includes third party, supply chain and distribution relationships, all of which expose industry participants to FCPA risk.
In this two-hour Live Webcast, a panel of distinguished professionals and thought leaders organized by The Knowledge Group will help Pharma/Life Sciences Industry understand the fundamental and complex aspects of this significant topic. They will provide an in-depth discussion of the various FCPA/Anti-Corruption compliance issues every Pharma/Life Sciences company should know. Speakers will also offer the audience with best practices in developing and implementing an effective compliance and risk management program.
Key topics include:
- FCPA/Anti-Corruption in Pharma/Life Sciences Industry: Current Trends
- Notable Cases for Guidance
- Common Anti-Corruption Risks
- Best Compliance Practices
- Risk Factor Management
About The Knowledge Group/The Knowledge Congress Live Webcast Series
The Knowledge Group was established with the mission to produce unbiased, objective, and educational live webinars that examine industry trends and regulatory changes from a variety of different perspectives. The goal is to deliver a unique multilevel analysis of an important issue affecting business in a highly focused format. To contact or register for an event, please visit: http://theknowledgegroup.org/.
Contact
The Knowledge Group
Thomas LaPointe, Jr., Executive Director
646-844-0200
www.theknowledgegroup.org
Therese Lumbao, Director
Account Management & Member Services
tlumbao@knowledgecongress.org
Thomas LaPointe, Jr., Executive Director
646-844-0200
www.theknowledgegroup.org
Therese Lumbao, Director
Account Management & Member Services
tlumbao@knowledgecongress.org
Contact
Categories